Association of amino acid imbalance with the severity of liver fibrosis and esophageal varices
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 3
Abstract
[b]Background[/b]. The relationships between the metabolic parameters and the endoscopic findings of esophageal varices have been poorly investigated. We investigated the association of the branched-chain amino acids totyrosine ratio (BTR) with the severity of liver fibrosis and esophageal varices. [b]Material and methods[/b]. We studied hepatitis C virus (HCV)-positive chronic liver disease patients who had undergone liver biopsy (n = 149). The relationship between the BTR values and the liver fibrotic stage was investigated. We also studied whether the BTR value was associated with the presence and bleeding risk of varices in patients with HCV-related compensated cirrhosis. [b]Results[/b]. The mean values of the BTR decreased with the progression of the fibrosis (METAVIR score: F0-1: 6.40 ± 1.19; F2: 5.85 ± 1.33; F3: 5.24 ± 0.97, F4: 4.78 ± 1.14). In the 58 patients with HCVrelated compensated cirrhosis, the mean values of the BTR decreased with the severity of varices (patients without varices: 5.01 ± 1.15, patients with a low-risk varices: 4.42 ± 1.06, patients with a high-risk varices: 3.86 ± 1.02). The BTR value was significantly lower in the patients with varices than in those without varices (4.17 ± 1.07 vs. 5.01 ± 1.15, P < 0.01). The BTR value was also significantly lower in the patients with a high risk of hemorrhage than in those with a low risk (3.86 ± 1.02 vs. 4.78 ± 1.14, P < 0.01). Furthermore, the BTR value was the most significantly different parameter, with the smallest P-value among all the factors examined, including the platelet count and albumin level. [b]Conclusion[/b]. A decreased BTR value was found to be associated with the progression of liver fibrosis and severity of varices.
Authors and Affiliations
Enomoto Hirayuki , Sakai Yoshiyuki , Aizawa Nobuhiro, Iwata Yoshinori, Tanaka Hironori, Ikeda Naoto, Hasegawa Kunihiro, Yoh Kazunori, Ishii Akio, Takashima Tomoyuki, Saito Masaki, Imanishi Hiroyasu, Iijima Hiroko, Nishiguchi Shuhei
Pegylated interferon, but not conventional interferon therapy induced severe skin lesions
Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is considered to be a manifestation of liver metabolic damage and is related to insulin resistance and genetic susceptibility. Inflammation mediated by Kupffer cells (KCs) is of...
The treatment of diabetes mellitus of patients with chronic liver disease
About 80% of patients with liver cirrhosis may have glucose metabolism disorders, 30% show overt diabetes mellitus (DM). Prospective studies have demonstrated that DM is associated with an increased risk of hepatic compl...
Predictive role BLVRA mRNA expression in hepatocellular cancer
Introduction and aim. Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor. It is primarily causedby hepatic cirrhosis or chronic viral hepatitis. Hepatic carcinogenesis is associated with inc...
Fatal rhinocerebral mucormycosis under the shade of hepatic encephalopat
Mucormycosis is an acutely fatal infection that occurs in immuncompromised patients. Cirrhosis is an acquired immune deficiency state and those patients are more prone to develop opportunistic infections. A 42-years-old...